mass

Led by Legend Capital, Multi-omics-leading Enterprise APTBIO Closes Series B with Hundreds of Millions of CNY

HONG KONG, Aug 19, 2022 – (ACN Newswire via SEAPRWire.com) – Shanghai Applied Protein Technology Co., Ltd. (“APTBIO”), a leading enterprise focused on mass spectrometry-based multi-omics applied to precision medicine, recently announced the completion of its Series B with hundreds of millions of CNY, which is led by Legend Capital. The proceeds from this round... » read more

兆科眼科(6622.HK)两项产品通过国家药监局药品注册现场核查及GMP符合性检查

HONG KONG, May 24, 2021 – (亚太商讯 via SEAPRWire.com) – 致力于眼科疗法的研究、开发及商业化的眼科制药公司——兆科眼科有限公司(「兆科眼科」或「公司」；股份代号：662...

Fujitsu and Hokkaido University Develop “Explainable AI” Technology Providing Users with Concrete Steps to Achieve Desired Outcomes

KAWASAKI, Japan, Feb 4, 2021 – (JCN Newswire) – Fujitsu Laboratories Ltd. and Hokkaido University today announced the development of a new technology based on the principle of “explainable AI” that automatically presents users with steps needed to achieve a desired outcome based on AI results about data, for example, from medical checkups. “Explainable AI”... » read more